2003The Journal of PediatricsRequires access

Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease

Timothy F. Feltes, Allison K. Cabalka, H. Cody Meissner, Franco M. Piazza, David A Carlin, Franklin H. Top, Edward M. Connor, Henry M. Sondheimer, for the Cardiac Synagis Study Group

Open publisher page 831 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 831 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Palivizumab, Medicine, Placebo, Adverse effect, Heart disease, Pediatrics, Randomized controlled trial, Respiratory system

Related papers

Back to paper searchBrowse research topicsOriginal source
Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease — Research Paper | ScholarLens